secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2023-06-12T23:59:59+00:00
Accession:  0001193125-23-165273
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis closes $575M convertible notes offering, repurchases $434.1M of 2024 notes
--------------------------------------------------------------------------------

- Issued $575M aggregate principal of 1.75% convertible senior notes due 2028, including full exercise of greenshoe.
- Net proceeds approximately $560.8M after deducting discounts, commissions, and offering expenses.
- Used $420.4M of net proceeds to repurchase $434.1M in aggregate principal of its 0.125% convertible notes due 2024.
- Initial conversion price $53.73 per share, representing a 32.5% premium over the June 7, 2023 closing price of $40.55.
- Remaining proceeds expected to fund additional 2024 note repurchases, repayment at maturity, and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000119312523165273/0001193125-23-165273-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000119312523165273/d511748d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-165273

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer